Table 5. Multivariate Cox regression analysis for female breast cancer survival.
| Variable | B | SE | Wald χ2 | P | HR (95% CI) |
|---|---|---|---|---|---|
| T stage | 1.209 | 0.449 | 0.018 | 0.667 | 1.015 (0.323–3.277) |
| TNM stage | −2.150 | 0.731 | 9.477 | 0.002 | 0.105 (0.045–0.411) |
| ER status | 1.337 | 3.252 | 0.132 | 0.773 | 2.208 (0.112–7.868) |
| PR status | −2.633 | 3.666 | 0.436 | 0.455 | 0.179 (0.110–2.799) |
| Chemotherapy | 1.871 | 0.585 | 9.226 | 0.001 | 6.496 (2.223–18.450) |
| Endocrine therapy | 2.600 | 0.707 | 8.113 | 0.004 | 11.433 (2.277–29.458) |
ER, estrogen receptor; PR, progesterone receptor; HR, hazard ratio; CI, confidence interval.